Michael S Garshick
Overview
Explore the profile of Michael S Garshick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
425
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akinlonu A, Boffa M, Lyu C, Zhong J, Jindal M, Fadzan M, et al.
J Clin Lipidol
. 2025 Jan;
19(1):39-50.
PMID: 39828454
Background: Lipoprotein(a) [Lp(a)] is a driver of residual cardiovascular risk. Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) decrease Lp(a) with significant heterogeneity in response. We investigated contributors to the heterogeneous...
2.
Malandrino D, Weber B, Garshick M, Abbate A
JACC Asia
. 2024 Nov;
4(10):732-734.
PMID: 39553908
No abstract available.
3.
Shah J, Shah K, Mandal S, Garshick M, Femia A
J Am Acad Dermatol
. 2024 Nov;
PMID: 39547326
No abstract available.
4.
Gelfand J, Song W, Langan S, Garshick M
Nat Rev Cardiol
. 2024 Nov;
PMID: 39537837
The skin and cardiovascular systems are connected in unique and meaningful ways, and many diseases conventionally considered as being limited to one organ system are more closely related than previously...
5.
Garshick M, Weber B, Gelfand J
JAMA Cardiol
. 2024 Sep;
9(11):961-963.
PMID: 39292493
No abstract available.
6.
Saha S, Ottensoser M, Weber B, Berger J, Garshick M
Int J Womens Dermatol
. 2024 Aug;
10(3):e172.
PMID: 39161757
No abstract available.
7.
Zhang R, Weber B, Araiza-Garaygordobil D, Garshick M
Curr Cardiol Rep
. 2024 Apr;
26(5):423-434.
PMID: 38573553
Purpose Of Review: Targeting traditional cardiovascular risk factors is effective in reducing recurrent cardiovascular events, yet the presence of residual cardiovascular risk due to underlying systemic inflammation is a largely...
8.
Hamo C, Schlamp F, Drenkova K, Jindal M, Fadzan M, Akinlonu A, et al.
Am Heart J
. 2024 Jan;
269:201-204.
PMID: 38199832
Background: Cardiometabolic risk factors diabetes, obesity, and hypertension are highly prevalent and contribute to increased cardiovascular disease (CVD). Endothelial dysfunction precedes CVD development. The current study aimed to investigate the...
9.
Song W, Garshick M, Barbieri J, Shin D, Baez S, Papadopoulos M, et al.
J Invest Dermatol
. 2024 Jan;
144(6):1405-1409.e1.
PMID: 38184142
No abstract available.
10.
Shah J, Shah K, Mazori D, Caplan A, Hejazi E, Garshick M, et al.
J Am Acad Dermatol
. 2023 Dec;
90(5):1013-1016.
PMID: 38160810
No abstract available.